Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
6.50
Dollar change
+0.15
Percentage change
2.36
%
Index- P/E- EPS (ttm)-1.72 Insider Own11.93% Shs Outstand47.11M Perf Week-0.00%
Market Cap306.21M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float41.49M Perf Month-2.40%
Income-59.88M PEG- EPS next Q- Inst Own13.83% Short Float0.12% Perf Quarter-2.55%
Sales0.00M P/S- EPS this Y- Inst Trans- Short Ratio3.42 Perf Half Y-21.02%
Book/sh-0.83 P/B- EPS next Y- ROA-66.75% Short Interest0.05M Perf Year84.66%
Cash/sh0.94 P/C6.93 EPS next 5Y- ROE-8035.57% 52W Range1.75 - 11.00 Perf YTD-10.72%
Dividend Est.- P/FCF- EPS past 5Y-0.33% ROI-260.20% 52W High-40.91% Beta0.20
Dividend TTM- Quick Ratio1.38 Sales past 5Y-62.19% Gross Margin- 52W Low271.42% ATR (14)0.41
Dividend Ex-Date- Current Ratio1.38 EPS Y/Y TTM-6.61% Oper. Margin0.00% RSI (14)49.09 Volatility5.34% 5.25%
Employees102 Debt/Eq- Sales Y/Y TTM-100.00% Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-61.33% Payout- Rel Volume0.32 Prev Close6.35
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsNov 13 AMC Avg Volume14.12K Price6.50
SMA200.72% SMA50-6.84% SMA200-8.32% Trades Volume4,481 Change2.36%
Date Action Analyst Rating Change Price Target Change
Dec-08-23Initiated Leerink Partners Outperform $11
Jan-06-21Initiated Evercore ISI Outperform
Mar-06-24 04:15PM
Feb-13-24 04:15PM
Jan-31-24 04:15PM
Jan-30-24 11:02AM
Jan-29-24 04:15PM
08:00AM Loading…
Jan-17-24 08:00AM
Jan-11-24 04:32PM
Dec-26-23 02:00AM
Dec-13-23 04:15PM
Dec-04-23 04:22PM
Nov-13-23 04:15PM
Nov-09-23 04:15PM
Nov-08-23 04:15PM
Nov-07-23 04:01PM
Nov-06-23 02:00AM
10:49AM Loading…
Nov-02-23 10:49AM
Nov-01-23 06:32PM
Oct-23-23 02:00AM
Oct-11-23 04:27PM
Oct-04-23 04:30PM
Sep-29-23 04:15PM
Sep-28-23 04:15PM
Sep-26-23 04:15PM
Sep-19-23 04:15PM
Sep-13-23 04:15PM
Sep-05-23 04:15PM
Aug-31-23 04:15PM
Aug-15-23 04:15PM
Aug-04-23 04:15PM
Jul-20-23 04:15PM
04:15PM Loading…
Jul-19-23 04:15PM
Jul-10-23 02:00AM
Jun-08-23 04:15PM
May-17-23 04:15PM
May-05-23 01:30AM
Apr-24-23 07:33PM
Apr-17-23 04:15PM
Apr-11-23 04:15PM
Mar-27-23 04:15PM
Mar-14-23 04:15PM
Feb-14-23 04:15PM
Jan-11-23 04:15PM
Dec-27-22 01:45AM
Dec-21-22 04:15PM
Dec-08-22 04:15PM
Nov-15-22 04:15PM
Nov-14-22 04:15PM
Nov-10-22 08:28AM
02:00AM
Nov-09-22 04:15PM
Nov-08-22 04:15PM
Nov-02-22 04:15PM
Oct-31-22 04:15PM
Oct-27-22 04:15PM
Oct-18-22 04:15PM
Oct-10-22 04:15PM
Sep-28-22 04:15PM
Sep-22-22 04:15PM
07:22AM
Sep-21-22 04:15PM
Sep-12-22 02:00AM
Sep-08-22 04:15PM
Sep-07-22 04:15PM
Sep-06-22 04:15PM
Aug-31-22 04:15PM
Aug-09-22 04:15PM
Jul-13-22 04:15PM
Jul-08-22 04:15PM
Jun-09-22 04:15PM
Jun-05-22 09:00AM
Jun-02-22 04:15PM
May-18-22 09:12PM
04:40PM
May-17-22 04:15PM
May-11-22 04:15PM
06:35AM
May-10-22 04:15PM
May-04-22 04:15PM
May-02-22 04:15PM
Apr-11-22 04:15PM
Apr-08-22 05:57PM
Apr-07-22 04:15PM
Mar-30-22 04:21PM
Mar-16-22 04:15PM
Mar-08-22 04:15PM
Feb-10-22 04:15PM
10:14AM
10:05AM
Feb-09-22 04:15PM
Jan-26-22 04:15PM
Jan-11-22 04:15PM
Jan-10-22 02:00AM
Jan-06-22 09:16AM
Jan-05-22 04:15PM
Jan-04-22 04:15PM
Dec-16-21 12:38PM
Dec-08-21 04:15PM
Nov-17-21 04:15PM
Nov-10-21 08:19AM
Nov-09-21 04:15PM
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Levy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.